Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Tag Archives: patents
CLS v. Alice Bank And The Cult Of The “Abstract Idea”
Ex-Judge Michel’s compelling amicus brief – more on that in a future post—prompted me to take a quick look back at the evolution “abstract idea” as a patent-ineligible category of invention. This category of patent-ineligible invention is listed, along with … Continue reading
Stories I Missed In 2013
Some IP Stories Do Not Have Much “It” Factor. Just like there used to be, and I guess still are, “It Girls” in showbiz and fashion, there are “It Issues” in IP law. I know these decisions/controversies are very important … Continue reading
Donald Chisum Monograph: Cert. Grant in CLS Bank: Background and Commentary
This is a guest post from the Chisum Patent Academy and is posted with their permission. Patents on Computer-Implemented Methods and Systems: The Supreme Court Grants Review (CLS Bank) (Dec. 10, 2013) The Chisum Patent Academy is pleased to provide … Continue reading
The Unacknowledged Role of Section 112 in the Myriad Decisions
Guest post from Paul Cole, Lucas & Co., UK; introduction by Warren Woessner. In this interesting note, Paul Cole explores the possible effect on the Fed. Cir. and Supreme Court’s decisions about the patent-eligibility of “genomic DNA” of the arguable … Continue reading
Posted in Patent Eligible Subject Matter
Tagged application to bacterial genes, biotechnology, biotechnology law, blanket prohibition, BRCA1, cDNA, chemist or geneticist, Enablement, evaluation, full-length gene partial sequence, intellectual property, ip, Myriad, Patent Law, patent-eligibility, patents, Paul Cole, structural difference threshold, utility threshold, Warren Woessner, written description
Leave a comment